<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[RSS Feed]]></title><description><![CDATA[RSS Feed]]></description><link>http://direct.ecency.com</link><image><url>http://direct.ecency.com/logo512.png</url><title>RSS Feed</title><link>http://direct.ecency.com</link></image><generator>RSS for Node</generator><lastBuildDate>Fri, 22 May 2026 08:55:36 GMT</lastBuildDate><atom:link href="http://direct.ecency.com/created/drugdevelopment/rss.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[Hope for Alzheimer's Patients: Biogen's Latest Drug Reverses Progression of Disease]]></title><description><![CDATA[A new drug from Biogen called BIIB080 has shown promising early results in reducing levels of tau protein, a toxic protein linked to Alzheimer's disease. A Phase Ib trial found that the drug reduced tau]]></description><link>http://direct.ecency.com/hive-196387/@fragmentarion/hope-for-alzheimers-patients-biogens-latest-drug-reverses-progression-of-disease</link><guid isPermaLink="true">http://direct.ecency.com/hive-196387/@fragmentarion/hope-for-alzheimers-patients-biogens-latest-drug-reverses-progression-of-disease</guid><category><![CDATA[hive-196387]]></category><dc:creator><![CDATA[fragmentarion]]></dc:creator><pubDate>Tue, 04 Apr 2023 07:27:15 GMT</pubDate><enclosure url="https://i.ecency.com/p/3LxrHFUF5NKf5XjRJR1Wbg4cEMSSxY6pk3qTTiskeNTsBYKPu7VtKZXgNMJkaEiHTMMqadF9ZCQizku55NeFNATwUv1CqEszBR967H2VCszirfDrrZjramUtxjdwTRhEuB4K86GWNSaChk6EPVgD2nboM5pT2WPTtB3h9hgQ1NcSi48UkAXPCcb56xdjfJQfJk4c8cfwSFk5HNJZfnZcBr5bLysmEePshMF4Hu?format=match&amp;mode=fit" length="0" type="false"/></item></channel></rss>